Investigators found that some patients with high-risk nonmetastatic hormone-sensitive prostate cancer were understaged by ...

Metastatic prostate cancer is cancer that began in the prostate but has spread to other parts of the body. There's no cure, but there are a number of effective treatments you can discuss with a ...

Lu rhPSMA-10.1 showed high tumor radiation with low healthy tissue exposure in a phase 1/2 trial for metastatic ...

Dr. Chandler Park sat down for an interview with CURE® to discuss the biggest takeaway from the 2025 ASCO GU Symposium in ...

While prostate cancer statistics may seem daunting, advances in detection, treatment, and active surveillance offer patients ...

Metastatic prostate cancer patients in the Capital Region now have a new treatment option at Ochsner MD Anderson Cancer ...

Brain metastases from prostate cancer (PC) seem to be more frequent than in the past, possibly because advances in the treatment of patients with castration-resistant PC have prolonged their survival.

The global market for prostate cancer market is likely to be valued at around USD 12.9 billion in 2025 and is projected to ...

Prostate cancer remains one of the most commonly diagnosed cancersworldwide, with 1.4 million new cases and over 375,000 ...

Recently, licensed and emerging treatments for metastatic castrate-resistant prostate cancer are transforming the prognosis for men whose disease has already progressed during or after docetaxel ...

U.S. deaths in 2024. 1.4 million new cases worldwide in 2022. Prostate cancer statistics can look scary: 34,250 U.S. deaths in 2024. 1.4 million new cases worldwide in 2022. Dr. Bruce Montgomery, a UW ...

Prostate cancer affects one in eight men during their lifetime, making it the second most common cancer among American males.